Rifampin levels, interferon-gamma release and outcome in complicated pulmonary tuberculosis

Tuberculosis

Volumn 87, Issue 6, 2007, Pages 557-564

  McIlleron, Helen ^a   Watkins, Marcia L ^a   Folb, Peter I ^a   Ress, Stanley R ^a   Wilkinson, Robert J ^b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Faculty of Health Sciences   (South Africa)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Cytokines; Mycobacterium tuberculosis; Pharmacokinetics

Indexed keywords

CREATININE; CYTOKINE; ETHAMBUTOL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE FREE SURVIVAL; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE RESPONSE; INTERFERON PRODUCTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTIBIOTICS, ANTITUBERCULAR; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-5; MALE; MIDDLE AGED; PROGNOSIS; RIFAMPIN; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULIN; TUBERCULOSIS, PULMONARY;

EID: 35348976121     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2007.08.002     Document Type: Article

References (21)

1. Zignol M., Hosseini M.S., Wright A., et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 194 (2006) 479-485
2. Chang K.C., Leung C.C., Yew W.W., Ho S.C., and Tam C.M. A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med 170 (2004) 1124-1130
3. Leung C.C., Li T., Lam T.H., et al. Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med 170 (2004) 1027-1033
4. Coker R., McKee M., Atun R., et al. Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 332 (2006) 85-87
5. Falzon D., Le Strat Y., Belghiti F., Infuso A., and EuroTB Correspondents. Exploring the determinants of treatment success for tuberculosis cases in Europe. Int J Tuberc Lung Dis 9 (2005) 1224-1229
6. Singhal M., Banavalikar J.N., Sharma S., and Saha K. Peripheral blood T lymphocyte subpopulations in patients with tuberculosis and the effect of chemotherapy. Tubercle 70 (1989) 171-178
7. Chan C.H., Lai C.K., Leung J.C., Ho A.S., and Lai K.N. Elevated interleukin-2 receptor level in patients with active pulmonary tuberculosis and the changes following anti-tuberculosis chemotherapy. Eur Respir J 8 (1995) 70-73
8. Wilkinson R.J., Vordermeier H.M., Wilkinson K.A., et al. Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J Infect Dis 178 (1998) 760-768
9. Lalvani A., Pathan A.A., McShane H., et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163 (2001) 824-828
10. De Jong B.C., Israelski D.M., Corbett E.L., and Small P.M. Clinical management of tuberculosis in the context of HIV infection. Annu Rev Med 55 (2004) 283-301
11. Wilkinson K.A., Kon O.M., Newton S.M., et al. Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis 193 (2006) 354-359
12. Ewer K., Millington K.A., Deeks J.J., Alvarez L., Bryant G., and Lalvani A. Dynamic antigen-specific T cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174 (2006) 831-839
13. Carrara S., Vincenti D., Petrosillo N., Amicosante M., Girardi E., and Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 38 (2004) 754-756
14. McIlleron H., Wash P., Burger A., Norman J., Folb P.I., and Smith P. Determinants of rifampicin, isoniazid, pyrazinamide and ethambutol pharmacokinetics in a cohort of tuberculosis patients. Antimicrob Agents Chemother 50 (2006) 1170-1177
15. Lalvani A., Nagvenkar P., Udwadia Z., et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 183 (2001) 469-477
16. Hirsch C.S., Toossi Z., Othieno C., et al. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 180 (1999) 2069-2073
17. Seah G.T., Scott G.M., and Rook G.A. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 181 (2000) 385-389
18. Boussiotis V.A., Tsai E.Y., Yunis E.J., et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 105 (2000) 1317-1325
19. Dieli F., Friscia G., Di Sano C., et al. Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy. J Infect Dis 180 (1999) 225-228
20. Chan J., Tian Y., Tanaka K.E., et al. Effects of protein calorie malnutrition on tuberculosis in mice. Proc Natl Acad Sci USA 93 (1996) 14857-14861
21. Verver S., Warren R.M., Beyers N., et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med 171 (2005) 1430-1435